Home > Analysis > Amgen Inc (AMGN)
Amgen Inc (AMGN) Share Price
Amgen Inc (AMGN) Share Price Analysis

Name: Amgen Inc (AMGN)

Description: One of the worlds leading biotech companies, with a presence in many key areas of medicine and a market cap of $144 billion.It beat on earnings last time out tightening guidance as it did so, noting that sales had risen by 5.0% YoY. All about the drug and treatment pipleline And its AMG 133 and AMG 786 anti-obesity treatments are currently trailing with data expected in iearly and late 2024 repectively.


The current Amgen Inc. (AMGN) stock price is $269.12 which is a change of -2.19 or 0.81% from the last closing price of 269.12 with 2,608,218 shares traded giving NASDAQ:AMGN a market capitalisation of $144,027,154,570. The most recent daily high has been 271.97 and daily low 268.82. The NASDAQ:AMGN share price 52 week high has been 288.46 and the 52 week low 211.71. Based on the most recent NASDAQ:AMGN share price opening of 269.12, the current NASDAQ:AMGN EPS (earnings per share) are 14.07 and the PE (price earnings ratio) is 19.13. Pricing data last updated 08/12/2023 16:00.


  • FWD Pe of 14.50 is undemanding
  • 74.4% owned by institutions
  • Has two anti obesity treatments on trial


  • Will be busy integrating recently acquired Horizon Therapeutics
  • Stock is down -6.70% post earnings
  • Sales outside the US appear to be slowing
  • Outlook

Win a £500 JISA contribution

Scroll to Top